Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19

Clinical Trial ID NCT01044069

PubWeight™ 52.05^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01044069

Top papers